UMM logo

The Maryland Center for Multiple Sclerosis

Physicians and Staff

Robert K. Shin, M.D.

Robert K. Shin, M.D.

Dr. Shin received his medical degree from the University of Pennsylvania. He completed a neurology residency and a multiple sclerosis fellowship at the Hospital of the University of Pennsylvania. He also completed a fellowship in neuro-ophthalmology at the Hospital of the University of Pennsylvania and the Scheie Eye Institute before arriving at the University of Maryland as an Assistant Professor in the Department of Neurology and in the Department of Ophthalmology and Visual Sciences.

Dr. Shin has a special interest in visual problems associated with multiple sclerosis, including optic neuritis and double vision. Dr. Shin is involved in many clinical trials for disease modifying therapies in multiple sclerosis. He lectures frequently locally and nationally on multiple sclerosis and neuro-ophthalmologic topics, and has received multiple awards and commendations for his teaching and clinical excellence.

To make an appointment to see Dr. Shin in the Neurology Ambulatory Care Center please call 410-328-5858. Dr. Shin can also be seen in the Department of Ophthalmology for MS-related visual problems. For an appointment to see Dr. Shin in the eye clinic please call 410-328-6533.

Administrative Office Address: Patient Appointment Address:
Maryland Center for MS
11 South Paca St., 4th floor
Baltimore, MD 21201
Phone 410-328-5605
Fax 410-328-5425
Neurology Ambulatory Center
16 South Eutaw Street, 3rd floor
Baltimore, MD 21201
Phone 410-328-5858
Fax 410-328-1149

Education and Training:
09/87 – 05/91 B.S. Yale University (Biology), cum laude
09/91 – 05/96 M.D. University of Pennsylvania
07/96 – 06/97

Intern in Medicine
Albert Einstein Medical Center, Philadelphia
07/97 – 06/00

Resident in Neurology
Hospital of the University of Pennsylvania, Philadelphia
07/00 – 06/01


Fellow in Neuro-Ophthalmology
Hospital of the University of Pennsylvania, Philadelphia
Scheie Eye Institute, Philadelphia
07/01 – 06/02

Fellow in Multiple Sclerosis
Hospital of the University of Pennsylvania, Philadelphia
 
Certifications
05/01 – present American Board of Psychiatry and Neurology (#50095)
 
Current Appointments
07/02 – present

Assistant Professor in Neurology and Ophthalmology and Visual Sciences
University of Maryland Medical System

Research Activities

Principal Investigator

  1. Natalizumab (Antegren) in combination with Avonex, Biogen-Idec
  2. Natalizumab (Antegren) in combination with Copaxone, Biogen-Idec
  3. ABOVE, Berlex
  4. Long term safety of Avonex, Biogen-Idec
  5. Rituximab in MS, Genentech

Sub Investigator

  1. Campath versus Rebif in early MS, Ilex Pharmaceuticals
  2. Copaxone 20 mg vs. 40 mg, Teva Neuroscience
  3. Copaxone in Clinically Isolated Syndrome, Teva Neuroscience
  4. Long Term Safety of Copaxone in MS, Teva Neuroscience
  5. Avonex in combination with Copaxone in MS, NIH funded
  6. Betaseron or Rebif switching to Copaxone or continuing cerrent treatment, Teva Neuroscience
  7. Oral Chemokine Antagonist in MS, Merck
  8. Anti IL-12 in early MS, Centocor
  9. 4-AP as symptomatic management in MS, Acorda
  10. Rebif vs. Copaxone, Serono

This page was last updated on: August 29, 2007.

For more information about the Maryland Center for Multiple Sclerosis,
please call 410-328-5605.